Healthcare News

NexTel Medical, OTCPK: MAJI, announced the execution of Definitive Purchase Agreements to acquire two prominent telehealth and clinical solutions platforms

En comparación con los pacientes que recibían únicamente terapia hormonal, los pacientes tenían nueve veces más probabilidades de que tras la cirugía quedara poco o ningún cáncer en la próstata, con...

Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....

Par rapport aux patients recevant une hormonothérapie seule, les patients avaient neuf fois plus de chances de ne présenter que peu ou pas de cancer résiduel dans la prostate après la chirurgie, avec...

CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted...

USOSM will match every donation to the OMS Foundation’s annual fund received now through June 30, for up to a total of $35,000.

NETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), today announced the appointment of Prof. Gabby Sarusi as Strategic Advisor to the...

Promising Phase 1 data for LB2501, a potential first‑in‑class CD19/CD20 dual‑targeting in vivo CAR-T therapy, as an off-the-shelf, single-infusion treatment for B‑cell malignanciesAn ORR of 100% (6/6)...

-​ The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + standard-of-care (SoC) regimen for the registrational program -​ -​ 30 mg onvansertib +...

Myriad Genetics announces the appointment of Raj Jampa as chief technology officer (CTO).